OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC

Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ...

IADA Caps Transformative Year, Expands Global Influence & Market Leadership

December 2025 IADA capped the year by appointing a new Board of Directors for AircraftExchange and announcing the ...